{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T12:49:51Z","timestamp":1732625391037,"version":"3.28.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Intensiva (English Edition)"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.medine.2024.06.020","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T14:03:09Z","timestamp":1720706589000},"page":"693-703","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implications of opioid-sparing medications in critically ill patients: A scoping review"],"prefix":"10.1016","volume":"48","author":[{"given":"Gabriella","family":"Gambadoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Erstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.medine.2024.06.020_bib0005","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.medine.2024.06.020_bib0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12630-014-0174-1","article-title":"Analgesic, sedative, antipsychotic, and neuromuscular blocker use in Canadian intensive care units: a prospective, multicentre, observational study","volume":"61","author":"Burry","year":"2014","journal-title":"Can J Anaesth"},{"issue":"15","key":"10.1016\/j.medine.2024.06.020_bib0015","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.medine.2024.06.020_bib0020","unstructured":"U.S. Department of Health and Human Services. Pain management best practices inter-agency task force report: updates, gaps, inconsistencies, and recommendations. https:\/\/www.hhs.gov\/sites\/default\/files\/pmtf-final-report-2019-05-23.pdf. May 23, 2019. Accessed April 20, 2023."},{"issue":"3","key":"10.1016\/j.medine.2024.06.020_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.medine.2024.06.020_bib0030","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/BOT.0000000000001430","article-title":"Clinical practice guidelines for pain management in acute musculoskeletal injury","volume":"33","author":"Hsu","year":"2019","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.medine.2024.06.020_bib0035","unstructured":"American College of Surgeons. Best Practices Guidelines: Acute pain management in trauma patients. https:\/\/www.facs.org\/media\/exob3dwk\/acute_pain_guidelines.pdf. November 2020. Accessed April 20, 2023."},{"key":"10.1016\/j.medine.2024.06.020_bib0040","unstructured":"ICSI. Pain; assessment, non-opioid treatment approaches and opioid management. https:\/\/www.icsi.org\/wp-content\/uploads\/2021\/11\/Pain-Interactive-7th-V2-Ed-8.17.pdf. August 2017. Accessed April 20, 2023."},{"issue":"2","key":"10.1016\/j.medine.2024.06.020_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","volume":"17","author":"Chou","year":"2016","journal-title":"J Pain"},{"issue":"7","key":"10.1016\/j.medine.2024.06.020_bib0050","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000157","article-title":"Adjuvant analgesic use in the critically ill: a systematic review and meta-analysis","volume":"2","author":"Wheeler","year":"2020","journal-title":"Crit Care Explor"},{"issue":"11","key":"10.1016\/j.medine.2024.06.020_bib0055","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/j.pain.0000000000002283","article-title":"Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: initiative on methods, measurement, and pain assessment in clinical trials recommendations","volume":"162","author":"Gewandter","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.medine.2024.06.020_bib0060","unstructured":"Food and Drug Administration. Development of non-opioid analgesics for acute pain: guidance for industry (February 2022). https:\/\/www.fda.gov\/media\/156063\/download. (Accessed 2023 April 20)."},{"issue":"7","key":"10.1016\/j.medine.2024.06.020_bib0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.medine.2024.06.020_bib0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019215","article-title":"Comprehensive overview of computer-based health information tailoring: a scoping review protocol","volume":"7","author":"Ghalibaf","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.medine.2024.06.020_bib0075","article-title":"Comparison between dexmedetomidine and midazolam for sedation in patients with intubation after oral and maxillofacial surgery","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.medine.2024.06.020_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2019.09.016","article-title":"A randomized control trial comparing prophylactic dexmedetomidine versus clonidine on rates and duration of delirium in older adult patients undergoing coronary artery bypass grafting","volume":"61","author":"Shokri","year":"2020","journal-title":"J Clin Anesth"},{"issue":"1","key":"10.1016\/j.medine.2024.06.020_bib0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13019-020-01125-y","article-title":"Comparing the effects of ketorolac and paracetamol on postoperative pain relief after coronary artery bypass graft surgery. A randomized clinical trial","volume":"15","author":"Javaherforooshzadeh","year":"2020","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.medine.2024.06.020_bib0090","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fneur.2020.00744","article-title":"Safety, tolerability, and efficacy of pain reduction by gabapentin for acute headache and meningismus after aneurysmal subarachnoid hemorrhage: apilot study","volume":"11","author":"Dhakal","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.medine.2024.06.020_bib0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40560-021-00569-1","article-title":"Adjunctive ketamine for sedation in critically ill mechanically ventilated patients: an active-controlled, pilot, feasibility clinical trial","volume":"9","author":"Amer","year":"2021","journal-title":"J Intensive Care"},{"issue":"2","key":"10.1016\/j.medine.2024.06.020_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5152\/TJAR.2022.21366","article-title":"Gabapentin as add-on to fentanyl and midazolam in patients receiving mechanical ventilation: a randomized, blinded study","volume":"50","author":"Salarian","year":"2022","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"10.1016\/j.medine.2024.06.020_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcrc.2021.10.021","article-title":"Discharge prescribing of enteral opioids in opioid na\u00efve patients following non-surgical intensive care: a retrospective cohort study","volume":"68","author":"Tollinche","year":"2022","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.medine.2024.06.020_bib0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/10600280211016856","article-title":"Impact of opioid administration in the intensive care unit and subsequent use in opioid-na\u00efve patients","volume":"56","author":"Krancevich","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.medine.2024.06.020_bib0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5055\/jom.2018.0427","article-title":"Discharge prescribing of enteral opioids after initiation as a weaning strategy from continuous opioid infusions in the Intensive Care Unit","volume":"14","author":"Kram","year":"2018","journal-title":"J Opioid Manag"},{"issue":"4","key":"10.1016\/j.medine.2024.06.020_bib0120","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1164\/rccm.201912-2503OC","article-title":"New opioid use after invasive mechanical ventilation and hospital discharge","volume":"202","author":"Wunsch","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.medine.2024.06.020_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225787","article-title":"Persistent post-discharge opioid prescribing after traumatic brain injury requiring intensive care unit admission: aross-sectional study with longitudinal outcome","volume":"14","author":"Dunn","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.medine.2024.06.020_bib0130","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamasurg.2019.0899","article-title":"New persistent opioid use after postoperative intensive care in US veterans","volume":"154","author":"Karamchandani","year":"2019","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.medine.2024.06.020_bib0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.medin.2019.07.013","article-title":"Evidence-based clinical practice guidelines for the management of sedoanalgesia and delirium in critically ill adult patients","volume":"44","author":"Celis-Rodr\u00edguez","year":"2020","journal-title":"Med Intensiva (Engl Ed)"},{"issue":"5","key":"10.1016\/j.medine.2024.06.020_bib0140","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1164\/rccm.202104-1012LE","article-title":"Opioids for sedation: has the pendulum swung too far?","volume":"204","author":"Murray","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.medine.2024.06.020_bib0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.medin.2013.03.008","article-title":"Indicaciones de la dexmedetomidina en las tendencias actuales de sedoanalgesia en el paciente cr\u00edtico [Indications of dexmedetomidine in the current sedoanalgesia tendencies in critical patients]","volume":"38","author":"Romera Ortega","year":"2014","journal-title":"Med Intensiva"},{"issue":"4","key":"10.1016\/j.medine.2024.06.020_bib0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.medin.2019.09.010","article-title":"miembros del GTSAD SEMICYUC; Anexo. Miembros de GTSAD. Oversedation Zero as a tool for comfort, safety and intensive care unit management","volume":"44","author":"Caballero","year":"2020","journal-title":"Med Intensiva (Engl Ed)"},{"issue":"11","key":"10.1016\/j.medine.2024.06.020_bib0155","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamainternmed.2022.3680","article-title":"Perioperative gabapentin use and in-hospital adverse clinical events among older adults after major surgery","volume":"182","author":"Park","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.medine.2024.06.020_bib0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamainternmed.2022.5268","article-title":"Trends in the concurrent prescription of opioids and gabapentin in the US, 2006 to 2018","volume":"183","author":"Peet","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"24","key":"10.1016\/j.medine.2024.06.020_bib0165","first-page":"2387","article-title":"Gabapentin increasingly implicated in overdose deaths","volume":"327","author":"Kuehn","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.medine.2024.06.020_bib0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.medin.2021.11.007","article-title":"Is the reduction of opiates in the critic patient really possible?","volume":"46","author":"Garc\u00eda S\u00e1nchez","year":"2022","journal-title":"Med Intensiva (Engl Ed)"}],"container-title":["Medicina Intensiva (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572724001747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572724001747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:59:33Z","timestamp":1732622373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173572724001747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2173572724001747"],"URL":"https:\/\/doi.org\/10.1016\/j.medine.2024.06.020","relation":{},"ISSN":["2173-5727"],"issn-type":[{"type":"print","value":"2173-5727"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of opioid-sparing medications in critically ill patients: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Medicina Intensiva (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medine.2024.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.medin.2024.06.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. and SEMICYUC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}